Tonix’s long Covid-19 drug fails to meet mid-stage trial goal
Tonix Pharmaceuticals Holding Corp said on Tuesday its experimental drug failed to meet the primary goal in a mid-stage study for management of widespread muscle pain and tenderness associated with long Covid-19. Shares of the company were down 12% in premarket trading. The 63-patient study was designed to monitor the intensity of pain in patients who had long Covid-19 and administered either the drug, TNX-102 SL, or placebo, but the […]
